Mark Olfson, MD, MPH

JCP
Original Research

May 28, 2019

When patients present for treatment of anxiety or mood disorders, do you consider whether there is also an untreated substance use disorder? Check out these data on disorder prevalence...
, , , et al
JCP
Commentary

March 5, 2019

Read expert commentary on guidelines for treatment-resistant schizophrenia (TRS) to make more informed treatment decisions.
, , , et al
JCP
Original Research

October 9, 2018

Psychiatric disorders often co-occur, and comorbidity patterns as well as suicide risk vary across the lifespan. Read this article to learn if suicide attempt risk in older and younger...
, , , et al
JCP
Original Research

September 11, 2018

Insomnia has been linked to several medical conditions, but the relationship between insomnia and these conditions can be unclear. Read this article to learn more about the connection between...
, , , et al
JCP
Original Research

July 31, 2018

Many individual factors influence risk of suicide attempt. How can these disparate factors be understood in light of each other? Read this article to learn about a comprehensive model...
, , , et al
JCP
Letter to the Editor

October 25, 2017

, , , et al
JCP
Original Research

August 23, 2017

When children as young as 3 years old are prescribed anticonvulsants, antipsychotics, or psychotropic polypharmacy for their first diagnosis of ADHD, what is the trajectory of treatment in subsequent...
, , , et al
JCP
Original Research

July 18, 2017

In 2015, the FDA removed WBC monitoring altogether and reduced the threshold for ANCs before interruption of clozapine treatment was required. The current study looks at almost 250 clozapine-treated...
, , , et al
JCP
Original Research

July 5, 2017

Antipsychotic medications are increasingly prescribed to treat depression. But is this use always warranted? Read the article by Gerhard and colleagues to learn how often antipsychotics are prescribed in...
, , , et al
JCP
Article

March 29, 2017

The increasing overlap of mood disorders and antipsychotic use in youth is a growing area of concern. This meta-analysis examined the current findings on the frequency of mood disorders...
, , , et al
JCP
Original Research

January 25, 2017

If clinical trials by design exclude as many as 85% of individuals with a target disorder, how can these studies be representative of the clinical population? Discover in this...
, , , et al
JCP
Original Research

December 28, 2016

, , , et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe